These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35364402)

  • 1. Mucormycosis in COVID-19: The Indian scenario.
    Ghosh R; Roy D; Benito-León J
    J Mycol Med; 2022 Aug; 32(3):101275. PubMed ID: 35364402
    [No Abstract]   [Full Text] [Related]  

  • 2. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).
    Karimi-Galougahi M; Arastou S; Haseli S
    Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565
    [No Abstract]   [Full Text] [Related]  

  • 3. The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?
    Gupta A; Sharma A; Chakrabarti A
    Indian J Ophthalmol; 2021 Jul; 69(7):1645-1647. PubMed ID: 34146000
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur VK; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Emerg Infect Dis; 2023 Jan; 29(1):8-19. PubMed ID: 36573628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rise of mucormycosis in Covid-19 patients in India.
    Bhatia M
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):137-138. PubMed ID: 34304680
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study.
    Biswal M; Gupta P; Kanaujia R; Kaur K; Kaur H; Vyas A; Hallur V; Behera B; Padaki P; Savio J; Nagaraj S; Chunchanur SK; Shwetha JV; Ambica R; Nagdeo N; Khuraijam R; Priyolakshmi N; Patel K; Thamke D; Dash L; Jadhav D; Bharmal R; Bhattacharya S; Rudramurthy SM; Chakrabarti A
    J Hosp Infect; 2022 Apr; 122():173-179. PubMed ID: 35124141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures.
    Rahman FI; Islam MR; Bhuiyan MA
    J Med Virol; 2021 Dec; 93(12):6447-6448. PubMed ID: 34260073
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report.
    Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M
    Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
    Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
    Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis of the Middle Ear and Neck Post COVID 19.
    Dongol K; Rayamajhi P; Pradhananga RB; Dulal M; Sedhai M; Gurung B
    J Nepal Health Res Counc; 2023 Mar; 20(3):812-815. PubMed ID: 36974881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
    Sharma S; Grover M; Bhargava S; Samdani S; Kataria T
    J Laryngol Otol; 2021 May; 135(5):442-447. PubMed ID: 33827722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
    Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
    Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could cattle dung burning have contributed to the epidemic of COVID-19-associated mucormycosis in India? Results of an experimental aero-mycological study.
    Kathirvel S; Muthu V; Rudramurthy SM; Kaur H; Chakrabarti A; Agarwal R
    Mycoses; 2022 Nov; 65(11):1024-1029. PubMed ID: 35726395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
    Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
    Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the second wave of COVID-19 in India.
    Asrani P; Eapen MS; Hassan MI; Sohal SS
    Lancet Respir Med; 2021 Sep; 9(9):e93-e94. PubMed ID: 34216547
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary : Combating COVID-19-associated mucormycosis with limited resources.
    Kim U; Kulkarni P; Saini P
    Indian J Ophthalmol; 2022 Jun; 70(6):2169. PubMed ID: 35648005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.